[{"address1": "Baarerstrasse 14", "city": "Zug", "zip": "6300", "country": "Switzerland", "phone": "41 41 561 32 77", "website": "https://www.crisprtx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. The company's CRISPR/Cas9 is a technology for gene editing which is the process of precisely altering specific sequences of genomic DNA. It has a portfolio of therapeutic programs across a range of disease areas, including hemoglobinopathies, CAR T cell therapies, in vivo, and type 1 diabetes, as well as develops investigational CAR T programs, including an autologous, gene-edited CAR T program targeting allogeneic chimeric antigen receptor T cell for autoimmune indications and oncology. The company's lead product candidate is CASGEVY, an ex vivo CRISPR/Cas9 gene-edited cell therapy for treating patients suffering from transfusion-dependent beta-thalassemia, severe sickle cell disease (SCD), and hemoglobinopathies in which a patient's hematopoietic stem and progenitor cells are edited to produce high levels of fetal hemoglobin in red blood cells. It also develops CAR T cell therapies, including CTX112 targeting cluster of differentiation 19 (CD19) and CTX131 targeting CD70 for oncology and autoimmune indications; CTX310 and CTX320, in vivo gene editing to address the cardiovascular disease by disrupting the validated targets angiopoietin-like protein 3 and lipoprotein; and CTX211, an allogeneic, gene-edited, hypoimmune stem cell-derived product candidate for the treatment of T1D. It has strategic partnerships with Vertex Pharmaceuticals Incorporated. CRISPR Therapeutics AG was incorporated in 2013 and is headquartered in Zug, Switzerland.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Samarth  Kulkarni Ph.D.", "age": 47, "title": "CEO & Chairman", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 1395001, "exercisedValue": 6400669, "unexercisedValue": 2024000}, {"maxAge": 1, "name": "Dr. Raju Yashaswi Prasad Ph.D.", "age": 41, "title": "Chief Financial Officer", "yearBorn": 1984, "fiscalYear": 2024, "totalPay": 755982, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James R. Kasinger J.D.", "age": 53, "title": "General Counsel & Secretary", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 756970, "exercisedValue": 0, "unexercisedValue": 2410088}, {"maxAge": 1, "name": "Dr. Naimish  Patel C.M., M.D.", "age": 53, "title": "Chief Medical Officer", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 917362, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Shaun  Foy CFA", "title": "Co-Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Emmanuelle Marie Charpentier Ph.D.", "title": "Co-Founder & Scientific Advisory Board Member", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Craig C. Mello Ph.D.", "title": "Scientific Founder & Advisory Board Member", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Chad A. Cowan Ph.D.", "age": 52, "title": "Scientific Founder", "yearBorn": 1973, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Matthew  Porteus M.D., Ph.D.", "age": 60, "title": "Scientific Founder & Advisory Board Member", "yearBorn": 1965, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Daniel G. Anderson Ph.D.", "title": "Scientific Founder & Advisory Board Member", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 9, "compensationRisk": 10, "shareHolderRightsRisk": 2, "overallRisk": 9, "governanceEpochDate": 1769904000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 48.93, "open": 49.74, "dayLow": 49.62, "dayHigh": 54.096, "regularMarketPreviousClose": 48.93, "regularMarketOpen": 49.74, "regularMarketDayLow": 49.62, "regularMarketDayHigh": 54.096, "payoutRatio": 0.0, "beta": 1.754, "forwardPE": -14.308053, "volume": 2463941, "regularMarketVolume": 2463941, "averageVolume": 1833461, "averageVolume10days": 1709050, "averageDailyVolume10Day": 1709050, "bid": 52.93, "ask": 53.19, "bidSize": 5, "askSize": 3, "marketCap": 5093940224, "fiftyTwoWeekLow": 30.04, "fiftyTwoWeekHigh": 78.48, "allTimeHigh": 220.2, "allTimeLow": 11.63, "priceToSalesTrailing12Months": 1451.265, "fiftyDayAverage": 54.354, "twoHundredDayAverage": 53.812725, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 3324858624, "profitMargins": 0.0, "floatShares": 92370505, "sharesOutstanding": 95985312, "sharesShort": 21888419, "sharesShortPriorMonth": 21051418, "sharesShortPreviousMonthDate": 1767139200, "dateShortInterest": 1769731200, "sharesPercentSharesOut": 0.2297, "heldPercentInsiders": 0.015829999, "heldPercentInstitutions": 0.73375, "shortRatio": 12.17, "shortPercentOfFloat": 0.2578, "impliedSharesOutstanding": 95985312, "bookValue": 20.041, "priceToBook": 2.6480713, "lastFiscalYearEnd": 1767139200, "nextFiscalYearEnd": 1798675200, "mostRecentQuarter": 1767139200, "netIncomeToCommon": -581598976, "trailingEps": -6.47, "forwardEps": -3.7091, "enterpriseToRevenue": 947.253, "enterpriseToEbitda": -6.058, "52WeekChange": -0.063002706, "SandP52WeekChange": 0.11471915, "quoteType": "EQUITY", "currentPrice": 53.07, "targetHighPrice": 316.0, "targetLowPrice": 32.0, "targetMeanPrice": 84.34783, "targetMedianPrice": 77.0, "recommendationMean": 1.96296, "recommendationKey": "buy", "numberOfAnalystOpinions": 23, "totalCash": 1975827968, "totalCashPerShare": 20.585, "ebitda": -548838976, "totalDebt": 206746000, "quickRatio": 13.25, "currentRatio": 13.316, "totalRevenue": 3510000, "debtToEquity": 10.758, "revenuePerShare": 0.039, "returnOnAssets": -0.15761, "returnOnEquity": -0.30181998, "grossProfits": -494776000, "freeCashflow": -205623744, "operatingCashflow": -345014016, "revenueGrowth": -0.976, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -179.125, "financialCurrency": "USD", "symbol": "CRSP", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "CRISPR Therapeutics AG", "longName": "CRISPR Therapeutics AG", "marketState": "CLOSED", "exchange": "NGM", "messageBoardId": "finmb_262549448", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 8.46107, "regularMarketPrice": 53.07, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1476883800000, "postMarketChangePercent": 0.433389, "postMarketPrice": 53.3, "postMarketChange": 0.22999954, "regularMarketChange": 4.14, "regularMarketDayRange": "49.62 - 54.096", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 1833461, "fiftyTwoWeekLowChange": 23.029999, "fiftyTwoWeekLowChangePercent": 0.7666444, "fiftyTwoWeekRange": "30.04 - 78.48", "fiftyTwoWeekHighChange": -25.410004, "fiftyTwoWeekHighChangePercent": -0.32377678, "fiftyTwoWeekChangePercent": -6.3002706, "corporateActions": [], "postMarketTime": 1771030734, "regularMarketTime": 1771016402, "earningsTimestampStart": 1778533200, "earningsTimestampEnd": 1778533200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -6.47, "epsForward": -3.7091, "epsCurrentYear": -4.94571, "priceEpsCurrentYear": -10.730512, "fiftyDayAverageChange": -1.2840004, "fiftyDayAverageChangePercent": -0.023622924, "twoHundredDayAverageChange": -0.7427254, "twoHundredDayAverageChangePercent": -0.013802039, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.0 - Buy", "cryptoTradeable": false, "trailingPegRatio": null, "__fetch_time": "2026-02-14"}]